Clinical Trial Update: Study to Evaluate Immunogenicity, Safety, and Tolerability of ZOSTAVAX™ Vaccine (Zoster Vaccine Live, V211) Administered Concomitantly Versus Nonconcomitantly With Quadrivalent Influenza Virus Vaccine (Inactivated) in Participants ≥50 Years of Age (V211-062) [Phase 3]

View source ↗

Summary

A Phase 3 study evaluating immunogenicity, safety, and tolerability of ZOSTAVAX administered concomitantly with quadrivalent influenza vaccine versus nonconcomi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Herpes Zoster

Drugs mentioned

• Zostavax (Varicella zoster vaccine live)

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Herpes Zoster | Phase 3 | Status: COMPLETED | Results posted: 2017-02-14